Showing results (281-290 of 9,661) with videos related to
Sort By:
Pageof 967
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.Leukemia|March 3, 2012
Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countriesB Chen, Y-Y Wang, Y Shen, et al.Leukemia|March 8, 2012
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cellsY Yu, L Yang, M Zhao, et al.Leukemia|October 22, 2011
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersT Bochtler, M Kirsch, B Maier, et al.Leukemia|September 5, 2008
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiationS Tavor, M Eisenbach, J Jacob-Hirsch, et al.Leukemia|September 5, 2008
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesisE Terpos, E Kastritis, M Roussou, et al.Leukemia|September 5, 2008
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeT Krejsgaard, L M Gjerdrum, E Ralfkiaer, et al.Leukemia|September 19, 2008
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculationR Landolfi, L Di Gennaro, A FalangaLeukemia|September 12, 2008
ICER expression inhibits leukemia phenotype and controls tumor progressionM Pigazzi, E Manara, E Baron, et al.Leukemia|September 12, 2008
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cellsC Nishioka, T Ikezoe, J Yang, et al.Pageof 967